Parameter | Category | DSS | MEFS | LRFS | |||
HR (95% CI) | p Value | HR (95% CI) | p Value | HR (95% CI) | p Value | ||
Rsf1 | Low expression (0+∼2+) | 1 (2.309 to 8.548) | <0.0001* | 1 (1.590 to 6.379) | 0.0011* | 1 (2.203 to 12.690) | 0.0002* |
Overexpression (3+∼4+) | 4.442 (–) | 3.185 (–) | 5.287 (–) | ||||
Nodal status (N) | N0–N1 | 1 (1.014 to 3.971) | 0.0454* | 1 (0.710 to 2.925) | 0.3114 | 1 (0.869 to 5.021) | 0.0998 |
N2–N3 | 2.007 (–) | 1.441 (–) | 2.089 (–) | ||||
Primary tumour (T) | T1–T2 | 1 (0.896 to 2.756) | 0.1134 | 1 (1.063 to 3.827) | 0.0319* | 1 (0.918 to 4.158) | 0.0823 |
T3–T4 | 1.583 | 2.017 (–) | 1.953 (–) | ||||
Histological grade | Keratinised/non-keratinised | 1 (0.808 to 2.273) | 0.2496 | 1 (0.856 to 3.175) | 0.1353 | ||
Undifferentiated | 1.355 (–) | 1.648 (–) | |||||
Therapeutic response | Complete response | 1 (0.844 to 5.572) | 0.1081 | ||||
Partial response | 2.168 (–) |
* and bold type, Statistically significant.
DSS, disease-specific survival; LRFS, local recurrence-free survival; MFS, metastasis-free survival.